the Context

The Obama Administration through the U.S. Treasury Department will clamp down further on corporate income tax-avoiding inversion deals by U.S. companies with foreign rivals. There is a pending inversion deal between U.S. drug maker Pfizer Inc. and smaller Irish competitor Allergan, Plc.

The U.S. Treasury Department will clamp down further this week on corporate income tax-avoiding "inversion" deals by U.S. companies with foreign rivals, according to a letter seen by Reuters on Wednesday.

  1. Reuters
  2. (Image)

Related: